Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HUBS vs GSK✓SelectedUSD · GSKHUBS vs GSK performance historyLatest closeAs of+0.98%11/20
Stock and ETF performance explorer

HUBS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+544.1%
GSK return
+91.2%
Excess return
+453.0%
Maximum drawdown
-80.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.0%-0.1%+1.1%+1.0%
7D-10.8%-5.3%-5.4%-8.8%
30D-22.4%-3.7%-18.8%-21.3%
3M-19.2%-7.3%-11.9%-17.0%
6M-4.7%-4.2%-0.4%-3.7%
YTD-51.7%+0.9%-52.6%-53.1%
1Y-45.7%+7.3%-53.0%-48.7%
3Y-59.2%+52.7%-112.0%-69.0%
5Y-76.4%+40.1%-116.5%-81.7%
10Y+238.4%+98.7%+139.6%+106.9%
All+544.1%+91.2%+453.0%+287.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling